Sunday, February 22, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home ETF

A Closer Look at the FlexShares US ESG ETF’s Portfolio and Costs

Kennethcix by Kennethcix
February 22, 2026
in ETF, S&P 500, Value & Growth
0
FlexShares STOXX US ESG Select Index Fund Stock
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

For investors seeking exposure to US companies with strong sustainability credentials, the FlexShares STOXX US ESG Select Index Fund offers a rules-based approach. The fund’s methodology applies a stringent filter, eliminating the bottom 50% of companies based on environmental and social metrics. This analysis examines the ETF’s current sector allocation, fee structure, and strategic considerations.

Fee Analysis and Competitive Positioning

A critical component for long-term investment returns is a fund’s expense ratio. This ETF maintains a total expense ratio (TER) of 0.32%, placing it within the second quintile of the most cost-effective funds in its peer group. An interesting note for cost projections is that a previous operating expense cap agreement with the advisor, Northern Trust Investments, expired on March 1, 2025. Despite this change, the TER has remained steady at 0.32%, indicating that the end of this subsidy has not, to date, resulted in higher fees for shareholders.

Current Sector Allocation and Income Dates

The portfolio’s composition reveals a significant concentration in three core sectors. Information technology is the dominant holding, representing 30.34% of the fund. It is followed by financial services at 17.91% and the healthcare sector at 10.95%. This weighting underscores a focus on large US corporations that typically maintain consistent scores in ESG rankings.

Should investors sell immediately? Or is it worth buying FlexShares STOXX US ESG Select Index Fund?

Income-focused investors should note a key date. The ETF’s ex-dividend date was set last Friday, making it the crucial cut-off for determining eligibility for the fund’s upcoming distribution to shareholders.

Investment Strategy and Forward Profile

The fund tracks an index that is rebalanced periodically to account for shifts in the constituent companies’ sustainability ratings. Investors are advised to monitor these rebalancing events, as downgrades in ESG scores can lead to the immediate exclusion of previously significant holdings.

With assets under management of approximately $124.02 million, the ETF provides a targeted vehicle for sustainable US market exposure. Its fee structure and rule-based exclusion of sectors involved in tobacco, thermal coal, or controversial weapons continue to define its investment profile in 2026. The next index adjustment will reveal which companies retain their place in this selectively screened portfolio.

Ad

FlexShares STOXX US ESG Select Index Fund Stock: Buy or Sell?! New FlexShares STOXX US ESG Select Index Fund Analysis from February 22 delivers the answer:

The latest FlexShares STOXX US ESG Select Index Fund figures speak for themselves: Urgent action needed for FlexShares STOXX US ESG Select Index Fund investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 22.

FlexShares STOXX US ESG Select Index Fund: Buy or sell? Read more here...

Tags: FlexShares STOXX US ESG Select Index Fund
Kennethcix

Kennethcix

Related Posts

Intuitive Surgical Stock
Analysis

Intuitive Surgical’s Growth Trajectory Gains Momentum with Key FDA Approval

February 22, 2026
Oxford Lane Capital Stock
Analysis

Oxford Lane Capital: A Strategic Pivot Amidst Valuation Concerns

February 22, 2026
IRSA Stock
Analysis

IRSA’s Financial Strategy: A Crucial Test for Investor Confidence

February 21, 2026
Next Post
Iovance Stock

Iovance Biotherapeutics: A Crucial Phase of Commercial Execution

Intuitive Surgical Stock

Intuitive Surgical's Growth Trajectory Gains Momentum with Key FDA Approval

Apple Stock

A Legal Reprieve and New Tariff Threats Reshape Apple's Financial Landscape

Recommended

2Seventy Bio Stock

The Final Chapter for 2Seventy Bio Shareholders

4 months ago
Rheinmetall Stock

European Defense Giant Rheinmetall Secures Multi-Billion Euro Vehicle Contract

4 months ago
Boeing Stock

Boeing Shares Gain Momentum from Defense Contract and Acquisition Progress

5 months ago
Bionxt Solutions Stock

BioNxt Solutions Secures Key Patent, Unlocks Major Market Potential

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Iovance Biotherapeutics: A Crucial Phase of Commercial Execution

A Closer Look at the FlexShares US ESG ETF’s Portfolio and Costs

Eli Lilly’s Dual Catalysts: Immunology Data and Analyst Confidence

XTI Aerospace Secures Strategic Funding from JPMorgan for Drone Expansion

Nio’s Battery Swap Success in China Contrasts with European Market Challenges

Oxford Lane Capital: A Strategic Pivot Amidst Valuation Concerns

Trending

Adyen NV Stock
Analysis

Adyen’s Path to Sustainable Growth: Balancing Investment and Profitability

by Rodolfo Hanigan
February 22, 2026
0

For investors in Adyen NV, the narrative is shifting from short-term volatility to the company's long-term strategic...

Apple Stock

A Legal Reprieve and New Tariff Threats Reshape Apple’s Financial Landscape

February 22, 2026
Intuitive Surgical Stock

Intuitive Surgical’s Growth Trajectory Gains Momentum with Key FDA Approval

February 22, 2026
Iovance Stock

Iovance Biotherapeutics: A Crucial Phase of Commercial Execution

February 22, 2026
FlexShares STOXX US ESG Select Index Fund Stock

A Closer Look at the FlexShares US ESG ETF’s Portfolio and Costs

February 22, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Adyen’s Path to Sustainable Growth: Balancing Investment and Profitability
  • A Legal Reprieve and New Tariff Threats Reshape Apple’s Financial Landscape
  • Intuitive Surgical’s Growth Trajectory Gains Momentum with Key FDA Approval

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com